Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Catasys Inc

(NASDAQ: CATS)
Add to Portfolio
-0.14 (-0.94%)
as of 13:36 EDT

Last 14.76
Change -0.14 (-0.94%)
Open 14.83
Prev. Close 14.90
Today's Range
14.61
15.22
52wk Range
7.51
20.83
Volume 33,075
Avg Volume 127,293
Sector SIC-8090 Services-Misc Health & Allied Services, NEC

Perfomance Comparison

Name Today 3-Month 1-Year
CATS -0.94% -18.04% +67.79%
DJIA -1.86% -1.44% +0.29%
S&P 500 -1.99% -1.02% +0.18%

Key Statistics

Annual EPS -0.88
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 254,820
Weighted Alpha +17.92
Standard Deviation +0.08
Profit Margin -3,745.66%
Beta 1.61

Growth Rates

YTD +59.55%
1-Year +59.87%
3-Year +71.26%
5-Year +21.14%
10-Year -4.49%

Opinion

Sell Hold Buy

Recent Headlines

Catasys Reports 2019 Second Quarter Financial Results

BusinessWire via COMTEX - Wed Aug 14, 04:05PM EDT
Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today reported its financial results for the second quarter ended June 30, 2019. The Company provides big data-base(full story)
CATS: 14.76 (-0.14), CATSD: 10.0000 (+1.1200)

Catasys Expands Partnership with Leading National

BusinessWire via COMTEX - Tue Aug 13, 08:30AM EDT
Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today announced the expansion of its OnTrak-A solution with a leading national health plan into six new states. OnT(full story)
CATS: 14.76 (-0.14), CATSD: 10.0000 (+1.1200)

Catasys Schedules 2019 Second Quarter Financial

BusinessWire via COMTEX - Mon Aug 12, 08:30AM EDT
Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter ended June 30, 2019, af(full story)
CATS: 14.76 (-0.14), CATSD: 10.0000 (+1.1200)

BriaCell Appoints Richard J. Berman to Board of

GlobeNewswire via COMTEX - Mon Aug 12, 06:30AM EDT
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that it has appointed M(full story)
BCTXF: 0.0400 (-0.0076), ADXS: 0.40 (-0.02), IMRN: 2.49 (-0.22), CATS: 14.76 (-0.14), CYRX: 22.53 (-1.20), BCT.VN: 0.060 (+0.005), BIVI: 0.0832 (+0.0032)

Catasys to Present at the Canaccord Genuity 39th

BusinessWire via COMTEX - Wed Jul 31, 08:30AM EDT
Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company's Chairman and CEO, is scheduled to present at the Canaccord Ge(full story)
CATS: 14.76 (-0.14), CATSD: 10.0000 (+1.1200)